Hepatitis B, Chronic: all 954 studies

Page 10 of 10. Open to participants first (147), then studies with results posted, then the rest; newest registration first within each.

• Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
• Long-term Study With ClevudineCompletedNCT00558818Phase 4
• Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedNCT00558493Phase 4
• To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedNCT00537537Phase 4
• Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B HepatitisCompletedNCT00536627Phase 1/2
• Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis BCompletedNCT00531167Phase 4
• Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedNCT00513968Phase 1
• Laboratory Profile of Hepatitis B and C in Users of a Reference ServiceCompletedNCT00512941
• An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00467545Phase 4
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.TerminatedNCT00460850Phase 4
• Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
• KRN7000 in Chronic Hepatitis BCompletedNCT00363155Phase 1/2
• A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
• Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)CompletedNCT00338780Phase 4
• Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
• Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis BCompletedNCT00291616Phase 4
• Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B InfectionCompletedNCT00277576Phase 1
• Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
• A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.CompletedNCT00275652Phase 3
• Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.CompletedNCT00263614
• Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis BCompletedNCT00230503Phase 2
• Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201TerminatedNCT00230490Phase 2
• Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
• Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNCT00226382Phase 4
• 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected PatientsTerminatedNCT00221286Phase 3
• Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2aCompletedNCT00199732
• Studies of Immune Responses in Patients With Chronic Hepatitis BCompletedNCT00155155
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis CStatus unknownNCT00154869Phase 3
• Long Term Follow-up of Pegylated-Interferon Alpha-2bCompletedNCT00146705
• Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)CompletedNCT00140725Phase 3
• Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis BCompletedNCT00132652Phase 3
• Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis BCompletedNCT00131742Phase 3
• Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis BCompletedNCT00128544Phase 2
• An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis BCompletedNCT00124241Phase 2
• Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)TerminatedNCT00120796Phase 3
• Long-Term Lamivudine Therapy for Chronic Hepatitis BCompletedNCT00120354Phase 4
• Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and DeltaStatus unknownNCT00117533Phase 4
• Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis BCompletedNCT00115245Phase 3
• Safety and Acceptability of a Vaginal MicrobicideCompletedNCT00111943Phase 2
• Entecavir for Subjects With Chronic Hepatitis B Infection: An Early Access ProgramNo longer availableNCT00096811
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis BCompletedNCT00071201Phase 3
• A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BCompletedNCT00057265Phase 3
• Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis BCompletedNCT00048945Phase 3
• An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNCT00042393
• Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis BTerminatedNCT00040144Phase 2
• Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.TerminatedNCT00037622Not applicable
• A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to LamivudineCompletedNCT00036608Phase 3
• A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e AntigenCompletedNCT00035789Phase 3
• A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E AntigenCompletedNCT00035633Phase 3
• Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus InfectionCompletedNCT00034359Phase 2
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
• Lamivudine for Chronic Hepatitis BCompletedNCT00001457Phase 2

← Hepatitis B, Chronic overview